Washington University in St. Louis School of Medicine-ko ikertzaileekin lankidetzan egindako argitalpenak (2)

2020

  1. BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial

    Nature Medicine, Vol. 26, Núm. 6, pp. 878-885

2015

  1. Bone metastases in lung cancer: Potential novel approaches to therapy

    American Journal of Respiratory and Critical Care Medicine, Vol. 192, Núm. 7, pp. 799-809